Hailong Zhang

Years Active: 2018-2023
Publications (10 Years): 5

This page only lists publications with an associated author ORCID identifier.

Publications

Jing Huang, Mengmeng Dai, Mingxia He, Weicheng Bu, Liwen Cao, Jing Jing, Run Cao, Hailong Zhang, Ke Men
Treatment of Ulcerative Colitis by Cationic Liposome Delivered NLRP3 siRNA. International journal of nanomedicine 18 (2023)
Lijie Zhang, Xingkun Zhang, Xiaoming Zhong, Mengya Fan, Guoliang Wang, Wei Shi, Ran Xie, Yinxiang Wei, Hailong Zhang, Xiangxu Meng, Yaohui Wang, Yuanfang Ma
Soluble Flt-1 in AMI Patients Serum Inhibits Angiogenesis of Endothelial Progenitor Cells by Suppressing Akt and Erk's Activity. Biology 11 (8) (2022)
Run Cao, Yuting Ma, Shaowei Li, Donghai Shen, Shuang Yang, Xuance Wang, Yue Cao, Zhizeng Wang, Yinxiang Wei, Shulian Li, Guangchao Liu, Hailong Zhang, Yaohui Wang, Yuanfang Ma
1,25(OH)2 D3 alleviates DSS-induced ulcerative colitis via inhibiting NLRP3 inflammasome activation. Journal of leukocyte biology 108 (1) (2020)
Hailong Zhang, Yuting Ma, Run Cao, Guanli Wang, Shaowei Li, Yue Cao, Hao Zhang, Meichen Liu, Guangchao Liu, Jun Zhang, Shulian Li, Yaohui Wang, Yuanfang Ma
Soluble uric acid induces myocardial damage through activating the NLRP3 inflammasome. Journal of cellular and molecular medicine 24 (15) (2020)
Hailong Zhang, Xi Chen, Beibei Zong, Hongmin Yuan, Zhizeng Wang, Yinxiang Wei, Xuance Wang, Guangchao Liu, Jun Zhang, Shulian Li, Guanchang Cheng, Yaohui Wang, Yuanfang Ma
Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation. Journal of cellular and molecular medicine 22 (9) (2018)

Hailong Zhang.css-eqlu8i{font-size:small;padding-left:4px;}